Llorenç Rovirosa

The Genome in a Three-Dimensional Context: Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer

B. Javierre, Llorenç Rovirosa, Alberto Ramos-Morales, 2020, Frontiers in Immunology.

The HDAC7–TET2 epigenetic axis is essential during early B lymphocyte development

I. Varela, T. Graf, B. Javierre, 2022, Nucleic acids research.

Low input capture Hi-C (liCHi-C) identifies promoter-enhancer interactions at high-resolution

D. Costa, B. Javierre, François Serra, 2022, bioRxiv.

CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival

F. Couch, J. Benítez, C. Lázaro, 2022, Cancers.

Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer

D. Arango, E. Lerma, J. Surrallés, 2020, Clinical Cancer Research.

Gefitinib andAfatinib ShowPotential Efficacy for Fanconi Anemia–Related Head and Neck Cancer

D. Arango, E. Lerma, T. Helleday, 2020 .

p53 rapidly restructures 3D chromatin organization to trigger a transcriptional response

B. Javierre, M. Graupera, J. L. Sardina, 2023, bioRxiv.

p53 rapidly restructures 3D chromatin organization to trigger a transcriptional response

B. Javierre, M. Graupera, J. L. Sardina, 2024, Nature communications.